Business · 01/10/2018Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Adaptive Designs for Clinical Trials of Drugs and Biologics
Summary
The Food and Drug Administration (FDA) has made available a draft guidance for industry on the use of adaptive designs in clinical trials for drugs and biologics, aiming to provide evidence of effectiveness and safety.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →